Daniel Clayton‐Chubb

500 total citations
27 papers, 194 citations indexed

About

Daniel Clayton‐Chubb is a scholar working on Epidemiology, Hepatology and Physiology. According to data from OpenAlex, Daniel Clayton‐Chubb has authored 27 papers receiving a total of 194 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 9 papers in Hepatology and 6 papers in Physiology. Recurrent topics in Daniel Clayton‐Chubb's work include Liver Disease Diagnosis and Treatment (14 papers), Liver Disease and Transplantation (5 papers) and Nutrition and Health in Aging (5 papers). Daniel Clayton‐Chubb is often cited by papers focused on Liver Disease Diagnosis and Treatment (14 papers), Liver Disease and Transplantation (5 papers) and Nutrition and Health in Aging (5 papers). Daniel Clayton‐Chubb collaborates with scholars based in Australia, United States and Germany. Daniel Clayton‐Chubb's co-authors include Stuart K. Roberts, Ammar Majeed, William Kemp, John Lubel, Peter Lange, Robyn L. Woods, John J. McNeil, David Simmons, Hans G. Schneider and Joanne Ryan and has published in prestigious journals such as Journal of Hepatology, Journal of the American Geriatrics Society and Nutrients.

In The Last Decade

Daniel Clayton‐Chubb

25 papers receiving 191 citations

Peers

Daniel Clayton‐Chubb
Jillian S. Sullivan United States
Filippo Numeroso Italy
Sanath Allampati United States
Abdulrahman Almaghamsi Saudi Arabia
T. Salewa Oseni United States
Elisa Manicardi Italy
Mustafa Yenigün Türkiye
Amy Monroe United States
Lauren J. Kim United States
Erika Tomsits Hungary
Jillian S. Sullivan United States
Daniel Clayton‐Chubb
Citations per year, relative to Daniel Clayton‐Chubb Daniel Clayton‐Chubb (= 1×) peers Jillian S. Sullivan

Countries citing papers authored by Daniel Clayton‐Chubb

Since Specialization
Citations

This map shows the geographic impact of Daniel Clayton‐Chubb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Clayton‐Chubb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Clayton‐Chubb more than expected).

Fields of papers citing papers by Daniel Clayton‐Chubb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Clayton‐Chubb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Clayton‐Chubb. The network helps show where Daniel Clayton‐Chubb may publish in the future.

Co-authorship network of co-authors of Daniel Clayton‐Chubb

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Clayton‐Chubb. A scholar is included among the top collaborators of Daniel Clayton‐Chubb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Clayton‐Chubb. Daniel Clayton‐Chubb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Forbes, Malcolm, Michael Berk, Daniel Clayton‐Chubb, et al.. (2025). Contribution of depression and cardiometabolic diseases and the role of depression treatment in survival and functioning in older adults. EClinicalMedicine. 82. 103182–103182.
2.
Clayton‐Chubb, Daniel, Stuart K. Roberts, Ammar Majeed, et al.. (2025). Scores to predict steatotic liver disease – correlates and outcomes in older adults. PubMed. 2(1). 9–9. 1 indexed citations
3.
Clayton‐Chubb, Daniel, William Kemp, Ammar Majeed, et al.. (2025). Steatotic Liver Disease in Older Adults: Clinical Implications and Unmet Needs. Nutrients. 17(13). 2189–2189. 1 indexed citations
4.
Con, Danny, et al.. (2024). Effect of Concurrent Metabolic Dysfunction-Associated Steatotic Liver Disease on Serial Non-invasive Fibrosis Markers in Chronic Hepatitis B. Digestive Diseases and Sciences. 69(4). 1496–1506. 1 indexed citations
5.
Clayton‐Chubb, Daniel, Stuart K. Roberts, Ammar Majeed, et al.. (2024). Associations between MASLD, atrial fibrillation, cardiovascular events, mortality and aspirin use in older adults. GeroScience. 47(1). 1303–1318. 11 indexed citations
6.
Clayton‐Chubb, Daniel, William Kemp, Ammar Majeed, et al.. (2024). Late-Life Metabolic Dysfunction-Associated Steatotic Liver Disease and its Association With Physical Disability and Dementia. The Journals of Gerontology Series A. 79(4). 12 indexed citations
7.
Clayton‐Chubb, Daniel, Elena S. George, Andrew T. Chan, et al.. (2024). Mediterranean Diet and Ultra-Processed Food Intake in Older Australian Adults—Associations with Frailty and Cardiometabolic Conditions. Nutrients. 16(17). 2978–2978. 8 indexed citations
8.
Topliss, Duncan J., Hans G. Schneider, Ego Seeman, et al.. (2024). Establishing the TSH reference intervals for healthy adults aged over 70 years: the Australian ASPREE cohort study. Clinical Chemistry and Laboratory Medicine (CCLM). 63(3). 611–620. 1 indexed citations
9.
Yeap, Bu B., Jocasta Ball, Daniel Clayton‐Chubb, et al.. (2024). Testosterone and the risk of incident atrial fibrillation in older men: further analysis of the ASPREE study. EClinicalMedicine. 72. 102611–102611. 7 indexed citations
10.
Clayton‐Chubb, Daniel, Ammar Majeed, Stuart K. Roberts, et al.. (2024). Serum Transaminases and Older Adults: Distribution and Associations With All-Cause Mortality. The Journals of Gerontology Series A. 79(11). 2 indexed citations
11.
Clayton‐Chubb, Daniel, Ammar Majeed, S.A. Roberts, et al.. (2024). SAT-464-YI Transaminases and older adults: distribution and associations with all-cause mortality. Journal of Hepatology. 80. S653–S653. 1 indexed citations
12.
Lange, Peter, Alisa Turbić, Daniel Clayton‐Chubb, et al.. (2024). Melatonin does not reduce delirium severity in hospitalized older adults: Results of a randomized placebo‐controlled trial. Journal of the American Geriatrics Society. 72(6). 1802–1809. 2 indexed citations
13.
Clayton‐Chubb, Daniel, William Kemp, Ammar Majeed, et al.. (2023). Metabolic dysfunction‐associated steatotic liver disease in older adults is associated with frailty and social disadvantage. Liver International. 44(1). 39–51. 28 indexed citations
14.
Clayton‐Chubb, Daniel, Ammar Majeed, John Lubel, et al.. (2023). Current understanding and future perspectives on the impact of changing NAFLD to MAFLD on global epidemiology and clinical outcomes. Hepatology International. 17(5). 1082–1097. 31 indexed citations
15.
Clayton‐Chubb, Daniel, et al.. (2023). Initial outcomes of a dedicated multidisciplinary non‐alcoholic fatty liver disease clinic: a retrospective cohort study. Internal Medicine Journal. 53(11). 2065–2072. 2 indexed citations
16.
Clayton‐Chubb, Daniel, William Kemp, Ammar Majeed, et al.. (2023). Understanding NAFLD: From Case Identification to Interventions, Outcomes, and Future Perspectives. Nutrients. 15(3). 687–687. 25 indexed citations
17.
Kemp, William, Daniel Clayton‐Chubb, Ammar Majeed, et al.. (2021). Impact of renaming NAFLD to MAFLD in an Australian regional cohort: Results from a prospective population‐based study. Journal of Gastroenterology and Hepatology. 37(2). 395–403. 9 indexed citations
18.
Newnham, Evan, et al.. (2021). Randomised clinical trial: adjunctive induction therapy with oral effervescent budesonide in newly diagnosed coeliac disease. Alimentary Pharmacology & Therapeutics. 54(4). 419–428. 5 indexed citations
19.
Con, Danny, et al.. (2019). Acute medical stabilisation of adults with anorexia nervosa: experience of a defined interdisciplinary model of care. Internal Medicine Journal. 50(1). 77–85. 10 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jillian S. Sullivan Breakdown of academic impact, for papers by Filippo Numeroso Breakdown of academic impact, for papers by Sanath Allampati Breakdown of academic impact, for papers by Abdulrahman Almaghamsi Breakdown of academic impact, for papers by T. Salewa Oseni Breakdown of academic impact, for papers by Elisa Manicardi Breakdown of academic impact, for papers by Mustafa Yenigün Breakdown of academic impact, for papers by Amy Monroe Breakdown of academic impact, for papers by Lauren J. Kim Breakdown of academic impact, for papers by Erika Tomsits
Rankless by CCL
2026